ReviewMediterranean journal of hematology and infectious diseases2025
How First-Line Therapy is Changing in Transplant-Eligible Multiple Myeloma Patients.
Yasmine Houbaida et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it